FIGURE

![FIGURE: Vaccine effectiveness data for JYNNEOS against diagnosed mpox infection in New York during the 2022 outbreak are presented. The analysis compares infection rates between vaccinated and unvaccinated individuals among men who have sex with men, the population most affected by the outbreak.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205166/bin/mm7220a4-F.jpg)

> Source: Eli S Rosenberg et al. "Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 20." *MMWR. Morbidity and mortality weekly report*, 2023. PMID: [37339074](https://pubmed.ncbi.nlm.nih.gov/37339074/)

<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205166/bin/mm7220a4-F.jpg" alt="Vaccine effectiveness data for JYNNEOS against diagnosed mpox infection in New York during the 2022 outbreak are presented. The analysis compares infection rates between vaccinated and unvaccinated individuals among men who have sex with men, the population most affected by the outbreak." />
  <figcaption>FIGURE. Vaccine effectiveness data for JYNNEOS against diagnosed mpox infection in New York during the 2022 outbreak are presented. The analysis compares infection rates between vaccinated and unvaccinated individuals among men who have sex with men, the population most affected by the outbreak.<br>  Source: Eli S Rosenberg et al. "Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 20." <em>MMWR. Morbidity and mortality weekly report</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37339074/">37339074</a></figcaption>
</figure>